Follow the progress of Hemolens Diagnostics
This website contains information intended only for persons professionally dealing with medical devices (e.g. for persons performing medical professions, for persons dealing with the distribution of medical devices). Please confirm that you are a medical device professional to proceed.
Follow the progress of Hemolens Diagnostics
September 2, 2022
Cardiolens FFR-CT Pro® is a precise diagnostic test, supporting doctors in diagnosing patients with suspected ischemic heart disease.
Cardiolens FFR-CT Pro® technology analyzes data from two non-invasive diagnostic methods: Cardiac Computed Tomography Angiography (CCTA) combined with Continuous Non-Invasive Blood Pressure (CNBP) to create a precision in personalized diagnostics of ischemic heart disease that has not been achieved before on the market.
Using this technology allows for precise and accurate anatomical and functional assessment of the coronary arteries by creating a digital twin of the patient’s coronary vessels (3D vascular models), while providing the results of a virtual fractional flow reserve (FFR) in the coronary arteries (LAD, RCA, LCX).
An invaluable benefit of using Cardiolens FFR-CT Pro® technology is eliminating hospital stay, reducing patient stress and supporting physicians’ therapeutic decisions.
